Page 12 - Aytu Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15 1 Million, an Increase of 377% Year-Over-Year

Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15 1 Million, an Increase of 377% Year-Over-Year
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Neos rxconnectJosh disbrowAytu bioscienceAytu bioscience incSecurities exchangeFood drug administrationConsumer healthNeos therapeuticsQuarter fiscalNet revenueChief executive officerSecurities actSecurities exchange actDrug administrationConsolidated statementsConsolidated balance sheets

Earnings Scheduled For February 11, 2021

Earnings Scheduled For February 11, 2021
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesNational retail propsExpedia groupResearch solutionsAlpine income prop trustPatrick industriesBluerock residential growth reit incCyberark softwareAlithya groupInmed pharmaceuticalsAffirm holdingsBrixmor property groupKimco realtyLimelight networksAlliancebernstein holdingInsight enterprises

Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021

Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Aytu bioscienceInnovus pharmaceuticals incNeos therapeutics incMackenzie partners incAytu bioscience incExchange commissionAytu biopharma incSecurities exchangeAdvisory groupSpecial meetingAytu biopharmaNeos therapeuticsNasdaq capitalMackenzie partnersProxy advisory groupInnovus pharmaceuticals

Aytu BioScience, Inc : Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021

(2) Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 4, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the Company ), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that the Company will present its operational results for the fiscal second quarter ended December 31, 2020 on February 11, 2021, at 4:30 p.m. ET. The Company will review accomplishments from the quarter and provide an overview of its business and growth strategy. Conference Call Information 201-689-8584 (international) The webcast will be accessible live and archived at the following link https://www.webcaster4.com/Webcast/Page/2142/39877 and on Aytu BioScience s website, within the Investors section under Events & Presentations, at aytubio.com, for 90 days.

Aytu bioscienceAytu bioscience incInnovus pharmaceuticals incLive conference callInnovus pharmaceuticalsBeyond humanபுதுமை மருந்துகள் இன்க்வாழ மாநாடு அழைப்புபுதுமை மருந்துகள்அப்பால் மனிதன்

Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021

Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Aytu bioscienceAytu bioscience incInnovus pharmaceuticals incLive conference callInnovus pharmaceuticalsBeyond humanபுதுமை மருந்துகள் இன்க்வாழ மாநாடு அழைப்புபுதுமை மருந்துகள்அப்பால் மனிதன்